Enhancement of tryptic digestibility of Milk beta-Lactoglobulin through treatment with recombinant Rice glutathione/Thioredoxin and NADPH Thioredoxin reductase/Thioredoxin systems
For off-label clinical use, it must come from a licensed 503A compounding pharmacy that manufactures under pharmaceutical-grade conditions with documented sterility testing, potency verification, and third-party quality standards
For example, it is effective for healing lesions from excessive NSAIDs or alcohol.[ref][ref] Another study found that BPC 157 counteracted stomach and liver lesions and various encephalopathies in NSAIDs and insulin rats. [ref] BPC-157 completely resolved symptoms after major intestinal surgery in rats
Pilie, PG, Giuliani, V, Wang, W, McGrail, DJ, Bristow, C, Ngoi, NY, Kyewalabye, K, Wani, K, Le, H, Campbell, E, Snchez, N, Yang, D, Gheeya, J, Goswamy, R, Holla, V, Shaw, KR, Meric-Bernstam, F, Liu, CY, Ma, X, Feng, N, Machado, AA, Bardenhagen, J, Vellano, CP, Marszalek, JR, Rajendra, E, Piscitello, D, Johnson, TI, Likhatcheva, M, Elinati, E, Majithiya, J, Neves, J, Grinkevich, V, Ranzani, M, Luzarraga, MR, Boursier, M, Armstrong, L, Geo, L, Lillo, G, Tse, WY, Lazar, A, Kopetz, S , Do, MK, Lively, S, Johnson, MG, Robinson, HM, Smith, GC, Carroll, C, Di, MF, Jones, PH, Heffernan, TP, Yap, TA
It has demonstrated a strong safety profile and is currently used for non-therapeutic experimental applications only